Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Teva Identifier
ABS-COPD-30065
ClinicalTrials.gov Identifier
NCT03256695
Study Status
Completed
Trial Condition(s)
Chronic Obstructive Pulmonary Disease
Interventions
Drug: Albuterol sulfate (ABS)
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
You are about to leave the Teva Pharmaceuticals global website
The website you are about to access may be governed by different regional policies, regulations or advertising codes. Please be sure to read the privacy policy and terms of use of the websites that you visit.
Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third party websites.